Ann: Funding for ATL1103 Phase II Trial and Pipel, page-15

re: Ann: Funding for ATL1103 Phase II Trial a... furniture, just took the question out of my mouth !

Overall ASX down almost 2% ,if u had green in your profile today , count yourself lucky !

Still waiting in que for .15,what a opportunity ! Some would have been happy today!


ANP has 4 products in its development pipeline,

But how good does this one sound -

ATL1102 (injection) has successfully completed a Phase II efficacy and safety trial, significantly reducing the number of brain lesions in patients with multiple sclerosis.

The Company also advises that previously reported licensing due diligence activities being conducted
by an international pharmaceutical company in relation to ATL1103 are progressing and ANP anticipates being in a position to report on any material outcomes from this process before the middle of this year.

Bring on Phase 3 , plus all the partners $$$$ .